UT Tyler School of Medicine Receives Approval for Biomedical Sciences PhD 

TYLER, Texas (May 19, 2025) – The University of Texas at Tyler School of Medicine received approval  from the Southern Association of Colleges and Schools Commission on Colleges for the first  integrated biomedical sciences PhD program in East Texas.

“Offering this degree is a significant milestone, adding to our institution’s reputation as the region’s hub of cutting-edge research,” said Dr. Sue Cox, School of Medicine dean. “We’re tremendously  excited for what this means for the future of health care in East Texas.”

In this program, students will study biochemistry and molecular biology to better understand  diseases and develop new treatments. Students will be required to explore a new area of research  and successfully write their own grant. The first class is slated to start in fall 2025.

“As part of the curriculum, these students will be given the opportunity to perform novel research  towards understanding the molecular, cellular and physiological basis of human diseases.,” said  Dr. Pierre Neuenschwander integrated biomedical sciences PhD program director. “It’s our hope to  leverage our status as an R2-level doctoral research institution and that our PhD students’ research will help inform our health care workforce to better care for East Texans.”

For more information, visit the PhD in Integrated Biomedical Sciences webpage.

With a mission to improve educational and health care outcomes for East Texas and beyond, UT  Tyler offers more than 90 undergraduate and graduate programs to more than 10,000 students.  Through its alignment with UT Tyler Health Science Center and UT Health East Texas, UT Tyler has  unified these entities to serve Texas with quality education, cutting-edge research and excellent  patient care. Classified by Carnegie as a doctoral research institution and by U.S. News & World  Report as a national university, UT Tyler has campuses in Tyler, Longview, Palestine and Houston.